TY - JOUR
T1 - Indications for and Diagnostic Efficacy of Open-Lung Biopsy in the Patient with Acquired Immunodeficiency Syndrome (AIDS)
AU - Pass, Harvey I.
AU - Potter, Dorothy
AU - Shelhammer, James
AU - Macher, Abe
AU - Ognibene, Frederick P.
AU - Longo, Dan L.
AU - Gelmann, Edward
AU - Masur, Henry
AU - Roth, Jack A.
N1 - Funding Information:
From the Thoracic Oncology Section, Surgery Branch, Laboratory of Pathology, and Medicine Branch of the National Cancer Institute, Laboratory of Clinical Investigation, National Institutes of Allergy and Infec-tious Diseases, and the Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
PY - 1986
Y1 - 1986
N2 - Pulmonary infiltrates in the patient with acquired immunodeficiency syndrome (AIDS) may be associated with a spectrum of unusual neoplastic and infectious process. Transbronchial biopsy frequently reveals the cause of these infiltrates; however, when transbronchial biopsy is nondiagnostic or contraindicated, or if the patient fails to improve after a diagnostic transbronchial biopsy, further investigation is warranted to direct appropriate therapy. Efficacy of 23 open-lung biopsies in 19 AIDS patients with pulmonary infiltrates was evaluated to define the indications for and the diagnostic yield of open-lung biopsy. Pulmonary infiltrates were recognized for a mean duration (± standard error) of 16 ± 2 days before open-lung biopsy and were associated with fever and cough. These patients did not have prior transbronchial biopsy, and open-lung biopsy was diagnostic in all of these. Prior transbronchial biopsy performed in the remaining 16 patients was nondiagnostic in 10. Open-lung biopsy was diagnostic in 70% of these patients (Pneumocystis carinii pneumonia, 2 patients; Kaposi's sarcoma, 3 patients; Kaposi's sarcoma and Legionella pneumophila, 1 patient; cytomegalovirus, 1 patient). The other 6 patients having a previous diagnostic transbronchial biopsy failed to improve with therapy, and open-lung biopsy resulted in a therapeutic change in 67% of these patients. Two deaths were attributable to open-lung biopsy in patients with postoperative thrombocytopenic hemorrhage. Open-lung biopsy should be performed in AIDS patients when transbronchial biopsy is nondiagnostic or contraindicated, or in patients who fail to improve with appropriate therapy after diagnostic trans-bronchial biopsy, especially in patients with Kaposi's sarcoma. The diagnostic yield will be high, and major therapeutic changes will be instituted.
AB - Pulmonary infiltrates in the patient with acquired immunodeficiency syndrome (AIDS) may be associated with a spectrum of unusual neoplastic and infectious process. Transbronchial biopsy frequently reveals the cause of these infiltrates; however, when transbronchial biopsy is nondiagnostic or contraindicated, or if the patient fails to improve after a diagnostic transbronchial biopsy, further investigation is warranted to direct appropriate therapy. Efficacy of 23 open-lung biopsies in 19 AIDS patients with pulmonary infiltrates was evaluated to define the indications for and the diagnostic yield of open-lung biopsy. Pulmonary infiltrates were recognized for a mean duration (± standard error) of 16 ± 2 days before open-lung biopsy and were associated with fever and cough. These patients did not have prior transbronchial biopsy, and open-lung biopsy was diagnostic in all of these. Prior transbronchial biopsy performed in the remaining 16 patients was nondiagnostic in 10. Open-lung biopsy was diagnostic in 70% of these patients (Pneumocystis carinii pneumonia, 2 patients; Kaposi's sarcoma, 3 patients; Kaposi's sarcoma and Legionella pneumophila, 1 patient; cytomegalovirus, 1 patient). The other 6 patients having a previous diagnostic transbronchial biopsy failed to improve with therapy, and open-lung biopsy resulted in a therapeutic change in 67% of these patients. Two deaths were attributable to open-lung biopsy in patients with postoperative thrombocytopenic hemorrhage. Open-lung biopsy should be performed in AIDS patients when transbronchial biopsy is nondiagnostic or contraindicated, or in patients who fail to improve with appropriate therapy after diagnostic trans-bronchial biopsy, especially in patients with Kaposi's sarcoma. The diagnostic yield will be high, and major therapeutic changes will be instituted.
UR - http://www.scopus.com/inward/record.url?scp=0022635135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022635135&partnerID=8YFLogxK
U2 - 10.1016/S0003-4975(10)62776-2
DO - 10.1016/S0003-4975(10)62776-2
M3 - Article
AN - SCOPUS:0022635135
VL - 41
SP - 307
EP - 312
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
SN - 0003-4975
IS - 3
ER -